Učitavanje...
PI3K/Akt/mTOR inhibitors in breast cancer
Activation of the phosphoinositide 3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway is common in breast cancer. There is preclinical data to support inhibition of the pathway, and phase I to III trials involving inhibitors of the pathway have been or are being conducted in solid tumo...
Spremljeno u:
| Izdano u: | Cancer Biol Med |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Chinese Anti-Cancer Association
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4706528/ https://ncbi.nlm.nih.gov/pubmed/26779371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7497/j.issn.2095-3941.2015.0089 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|